Other

Proceeds from redemptions/sales of long-term investments

Pfizer Proceeds from redemptions/sales of long-term investments decreased by 85.1% to $88.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $82.00M to $88.00M. Over 4 years (FY 2021 to FY 2025), Proceeds from redemptions/sales of long-term investments shows an upward trend with a 14.0% CAGR.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
Metric ID: other_proceeds_from_sale_maturity_and_collection_of_long_6b146d

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$41.00M$272.00M$80.00M$52.00M$174.00M$220.00M$195.00M$124.00M$48.00M$17.00M$1.79B$305.00M$7.00M$1.23B$29.00M$82.00M$63.00M$359.00M$591.00M$88.00M
QoQ Change—+563.4%-70.6%-35.0%+234.6%+26.4%-11.4%-36.4%-61.3%-64.6%>999%-83.0%-97.7%>999%-97.6%+182.8%-23.2%+469.8%+64.6%-85.1%
YoY Change————+324.4%-19.1%+143.8%+138.5%-72.4%-92.3%+817.9%+146.0%-85.4%>999%-98.4%-73.1%+800.0%-70.8%>999%+7.3%
Range$7.00M – $1.79B
CAGR+17.4%
Avg YoY Growth+683.4%
Median YoY Growth+72.9%

Frequently Asked Questions

What is Pfizer's proceeds from redemptions/sales of long-term investments?
Pfizer (PFE) reported proceeds from redemptions/sales of long-term investments of $88.00M in Q1 2026.
How has Pfizer's proceeds from redemptions/sales of long-term investments changed year-over-year?
Pfizer's proceeds from redemptions/sales of long-term investments increased by 7.3% year-over-year, from $82.00M to $88.00M.
What is the long-term trend for Pfizer's proceeds from redemptions/sales of long-term investments?
Over 4 years (2021 to 2025), Pfizer's proceeds from redemptions/sales of long-term investments has grown at a 14.0% compound annual growth rate (CAGR), from $649.00M to $1.10B.